作为MPO-AAV诱导疗法的附加疗法,氧化:一项回顾性观察队列研究
Yizi Gong1,2,3,4, Ting Meng1, Wei Lin5
1Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Clinical kidney journal
|September 17, 2024
概括
氧化 (HCQ) 可能会改善肌氧化酶 (MPO) -抗营养素细胞质抗体 (ANCA) -相关血管炎 (AAV) 患者的缓解率. 这项研究发现HCQ是安全的,并且在诱导疗法期间与更好的患者存活率有关.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓氧化酶 (MPO) - 抗营养素细胞质抗体 (ANCA) - 相关血管炎 (AAV) 在标准诱导疗法下表现出不满意的缓解率.
- 改善MPO-AAV治疗结果至关重要.
- 氧化 (HCQ) 是一种抗疟疾药物,用于自身免疫性疾病.
研究的目的:
- 评估HCQ作为MPO-AAV诱导治疗期间的附加疗法的疗效和安全性.
- 为了比较接受HCQ和不接受HCQ的MPO-AAV患者之间的缓解率,存率和患者存活率.
主要方法:
- 从2021年1月到2023年9月对MPO-AAV患者进行的回顾性观察队列研究.
- 患者被分为HCQ和对照组,并进行倾向分数匹配.
- 评估的结果包括缓解,耐治疗性,1年脏存活率和1年患者存活率;记录了不良反应.
主要成果:
- 在HCQ和对照组之间观察到缓解,反应和治疗耐药性的统计学显著差异 (P = .021).
- 在1年存期中没有发现显著差异 (P = .789).
- 在HCQ组显示显著更好的1年患者存活率 (P = .049) 没有严重的不良反应报告.
结论:
- 氧化 (HCQ) 与标准诱导治疗相结合,可能会提高MPO-AAV患者的缓解率.
- HCQ似乎是MPO-AAV的诱导疗法的安全补充.
- 进一步的研究可能会探索HCQ在MPO-AAV.患者生存率改善中的作用.
更多相关视频
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.4K
04:43Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
Published on: June 16, 2023
886
相关概念视频
01:26Anticholinesterase Agents: Poisoning and Treatment
813
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
813
01:24Parkinson's Disease: Treatment
237
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
237
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
638
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
638